Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Indriwanto Sakidjan AtmosudigdoMichael Anthonius LimBasuni RadiJoshua HenrinaEmir YonasRachel VaniaRaymond Pranata

Published in: Clinical medicine insights. Endocrinology and diabetes (2021)

Dyslipidemia potentially increases mortality and severity of COVID-19. The association was stronger in patients with older age, male, and hypertension.PROSPERO Registration Number: CRD42020213491.

Keyphrases

coronavirus disease
sars cov
systematic review
blood pressure
cardiovascular events
physical activity
meta analyses
early onset
type diabetes
middle aged
community dwelling
randomized controlled trial
cardiovascular disease
coronary artery disease
case control